{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T04:06:45Z","timestamp":1776571605246,"version":"3.51.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006364","name":"INCa","doi-asserted-by":"crossref","award":["INCa-DHOS 2010"],"award-info":[{"award-number":["INCa-DHOS 2010"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006364","name":"INCa","doi-asserted-by":"crossref","award":["201108"],"award-info":[{"award-number":["201108"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10549-017-4542-8","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T19:21:20Z","timestamp":1508786480000},"page":"459-468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance"],"prefix":"10.1007","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7750-0519","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Abadie","sequence":"first","affiliation":[]},{"given":"Fr\u00e9d\u00e9rique","family":"Nguyen","sequence":"additional","affiliation":[]},{"given":"Delphine","family":"Loussouarn","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Pe\u00f1a","sequence":"additional","affiliation":[]},{"given":"Adelina","family":"Gama","sequence":"additional","affiliation":[]},{"given":"Natascha","family":"Rieder","sequence":"additional","affiliation":[]},{"given":"Anton","family":"Belousov","sequence":"additional","affiliation":[]},{"given":"Ingrid","family":"Bemelmans","sequence":"additional","affiliation":[]},{"given":"La\u00ebtitia","family":"Jaillardon","sequence":"additional","affiliation":[]},{"given":"Catherine","family":"Ibisch","sequence":"additional","affiliation":[]},{"given":"Mario","family":"Campone","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"4542_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00428-014-1593-7","volume":"465","author":"D Vuong","year":"2014","unstructured":"Vuong D, Simpson PT, Green B, Cummings MC, Lakhani SR (2014) Molecular classification of breast cancer. Virchows Arch 465:1\u201314","journal-title":"Virchows Arch"},{"key":"4542_CR2","unstructured":"NHS Cancer Screening Programmes and The Royal College of Pathologists (2005) Pathology Reporting of Breast Disease: A Joint Document Incorporating the Third Edition of the NHS Breast Screening Programme\u2019s Guidelines for Pathology Reporting in Breast Cancer Screening and the Second Edition of The Royal College of Pathologists\u2019 Minimum Dataset for Breast Cancer Histopathology. Sheffield. \n                        https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/541521\/pathology_reporting_of_breast_disease.pdf\n                        \n                    . Accessed 5 Nov 2016"},{"key":"4542_CR3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","volume":"20","author":"A Goldhirsch","year":"2009","unstructured":"Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Th\u00fcrlimann B, Senn HJ et al (2009) Strategies for subtypes\u2013dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 20:1319\u20131329","journal-title":"Ann Oncol"},{"key":"4542_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10549-010-0746-x","volume":"120","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Reis-Filho JS, Ellis IO (2010) Combinatorial biomarker expression in breast cancer. Breast Cancer Res Treat 120:293\u2013308","journal-title":"Breast Cancer Res Treat"},{"key":"4542_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1677\/ERC-08-0244","volume":"16","author":"C Lanari","year":"2009","unstructured":"Lanari C, Lamb CA, Fabris VT, Helguero LA, Soldati R, Bottino MC et al (2009) The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer 16:333\u2013350","journal-title":"Endocr Relat Cancer"},{"key":"4542_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235:177\u2013182","journal-title":"Science"},{"key":"4542_CR7","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869\u201310874","journal-title":"Proc Natl Acad Sci USA"},{"key":"4542_CR8","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367\u20135374","journal-title":"Clin Cancer Res"},{"key":"4542_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000279","author":"FM Blows","year":"2010","unstructured":"Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J et al (2010) Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS ONE. doi:\n                        10.1371\/journal.pmed.1000279","journal-title":"PLoS ONE"},{"key":"4542_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/PAP.0b013e318220f5d1","volume":"18","author":"EA Rakha","year":"2011","unstructured":"Rakha EA, Ellis IO (2011) Modern classification of breast cancer: should we stick with morphology or convert to molecular profile characteristics. Adv Anat Pathol 18:255\u2013267","journal-title":"Adv Anat Pathol"},{"key":"4542_CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al (2000) Molecular portraits of human breast tumours. Nature 406:747\u2013752","journal-title":"Nature"},{"key":"4542_CR12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13:674\u2013690","journal-title":"Nat Rev Clin Oncol"},{"key":"4542_CR13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MC Cheang","year":"2009","unstructured":"Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J et al (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101:736\u2013750","journal-title":"J Natl Cancer Inst"},{"key":"4542_CR14","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1200\/JCO.2010.31.2835","volume":"2029","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E et al (2011) Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 2029:4273\u20134278","journal-title":"J Clin Oncol"},{"key":"4542_CR15","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1158\/1078-0432.CCR-14-2552","volume":"21","author":"TO Nielsen","year":"2015","unstructured":"Nielsen TO, Perou CM (2015) CCR 20th anniversary commentary: the development of breast cancer molecular subtyping. Clin Cancer Res 21:1779\u20131781","journal-title":"Clin Cancer Res"},{"key":"4542_CR16","first-page":"455","volume":"25","author":"FL Queiroga","year":"2011","unstructured":"Queiroga FL, Raposo T, Carvalho MI, Prada J, Pires I (2011) Canine mammary tumours as a model to study human breast cancer: most recent findings. In Vivo 25:455\u2013465","journal-title":"In Vivo"},{"key":"4542_CR17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.trsl.2011.11.005","volume":"159","author":"SS Pinho","year":"2012","unstructured":"Pinho SS, Carvalho S, Cabral J, Reis CA, G\u00e4rtner F (2012) Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res 159:165\u2013172","journal-title":"Transl Res"},{"key":"4542_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2013.03.005","volume":"88","author":"G Ranieri","year":"2013","unstructured":"Ranieri G, Gadaleta CD, Patruno R, Zizzo N, Daidone MG, Hansson MG et al (2013) A model of study for human cancer: spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies. Crit Rev Oncol Hematol 88:187\u2013197","journal-title":"Crit Rev Oncol Hematol"},{"key":"4542_CR19","first-page":"141","volume":"78","author":"F Nguyen","year":"2017","unstructured":"Nguyen F, Pena L, Ibisch C, Loussouarn D, Gama A, Rieder N et al (2017) Canine invasive mammary carcinomas as models of human breast cancer: a retrospective observational study. Part 1: Natural history and prognostic factors. Breast Cancer Res Treat 78:141\u2013148","journal-title":"Breast Cancer Res Treat"},{"key":"4542_CR20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.rvsc.2009.04.016","volume":"87","author":"A Gama","year":"2009","unstructured":"Gama A, G\u00e4rtner F, Alves A, Schmitt F (2009) Immunohistochemical expression of epidermal growth factor receptor (EGFR) in canine mammary tissues. Res Vet Sci 87:432\u2013437","journal-title":"Res Vet Sci"},{"key":"4542_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1746-6148-6-5","author":"F Sassi","year":"2010","unstructured":"Sassi F, Benazzi C, Castellani G, Sarli G (2010) Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry. BMC Vet Res. doi:\n                        10.1186\/1746-6148-6-5","journal-title":"BMC Vet Res"},{"key":"4542_CR22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcpa.2012.08.009","volume":"148","author":"NH Kim","year":"2013","unstructured":"Kim NH, Lim HY, Im KS, Kim JH, Sur JH (2013) Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers. J Comp Pathol 148:298\u2013306","journal-title":"J Comp Pathol"},{"key":"4542_CR23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/0300985813498780","volume":"51","author":"KS Im","year":"2014","unstructured":"Im KS, Kim NH, Lim HY, Kim HW, Shin JI, Sur JH (2014) Analysis of a new histological and molecular-based classification of canine mammary neoplasia. Vet Pathol 51:549\u2013559","journal-title":"Vet Pathol"},{"key":"4542_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1670-6","author":"L Jaillardon","year":"2015","unstructured":"Jaillardon L, Abadie J, Godard T, Campone M, Loussouarn D, Siliart B et al (2015) The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study. BMC Cancer. doi:\n                        10.1186\/s12885-015-1670-6","journal-title":"BMC Cancer"},{"key":"4542_CR25","volume-title":"Histological classification of mammary tumors of the dog and cat","author":"W Misdorp","year":"1999","unstructured":"Misdorp W, Else RW, Hellmen E, Lipscomb TP (1999) Histological classification of mammary tumors of the dog and cat. Armed Forces Institute of Pathology, Washington DC"},{"key":"4542_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0300985810393258","volume":"48","author":"M Goldschmidt","year":"2011","unstructured":"Goldschmidt M, Pe\u00f1a L, Rasotto R, Zappulli V (2011) Classification and grading of canine mammary tumors. Vet Pathol 48:117\u2013131","journal-title":"Vet Pathol"},{"key":"4542_CR27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00428-008-0644-3","volume":"453","author":"A Gama","year":"2008","unstructured":"Gama A, Alves A, Schmitt F (2008) Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification. Virchows Arch 453:123\u2013132","journal-title":"Virchows Arch"},{"key":"4542_CR28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3109\/07357900009012210","volume":"18","author":"DM Vail","year":"2000","unstructured":"Vail DM, MacEwen EG (2000) Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 18:781\u2013792","journal-title":"Cancer Invest"},{"key":"4542_CR29","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ajpath.2013.05.033","volume":"183","author":"O Engebraaten","year":"2013","unstructured":"Engebraaten O, Vollan HK, B\u00f8rresen-Dale AL (2013) Triple-negative breast cancer and the need for new therapeutic targets. Am J Pathol 183:1064\u20131074","journal-title":"Am J Pathol"},{"key":"4542_CR30","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","volume":"103","author":"M Dowsett","year":"2011","unstructured":"Dowsett M, Nielsen TO, A\u2019Hern R, Bartlett J, Coombes RC, Cuzick J et al (2011) Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 103:1656\u20131664","journal-title":"J Natl Cancer Inst"},{"key":"4542_CR31","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/jnci\/djt306","volume":"105","author":"MY Polley","year":"2013","unstructured":"Polley MY, Leung SC, McShane LM, Gao D, Hugh JC, Mastropasqua MG et al (2013) An international Ki67 reproducibility study. J Natl Cancer Inst 105:1897\u20131906","journal-title":"J Natl Cancer Inst"},{"key":"4542_CR32","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.breast.2015.07.017","volume":"24","author":"C Denkert","year":"2015","unstructured":"Denkert C, Budczies J, von Minckwitz G, Wienert S, Loibl S, Klauschen F (2015) Strategies for developing Ki67 as a useful biomarker in breast cancer. Breast 24:S67\u2013S72","journal-title":"Breast"},{"key":"4542_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/104063870201400106","volume":"14","author":"G Sarli","year":"2002","unstructured":"Sarli G, Preziosi R, Benazzi C, Castellani G, Marcato PS (2002) Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. J Vet Diagn Invest 14:25\u201334","journal-title":"J Vet Diagn Invest"},{"key":"4542_CR34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/bjc.2015.437","volume":"114","author":"H Sung","year":"2016","unstructured":"Sung H, Garcia-Closas M, Chang-Claude J, Blows FM, Ali HR, Figueroa J et al (2016) Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers. Br J Cancer 114:298\u2013304","journal-title":"Br J Cancer"},{"key":"4542_CR35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/path.1559","volume":"203","author":"DM Abd El-Rehim","year":"2004","unstructured":"Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF et al (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203:661\u2013671","journal-title":"J Pathol"},{"key":"4542_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1636","author":"LG Fulford","year":"2007","unstructured":"Fulford LG, Reis-Filho JS, Ryder K, Jones C, Gillett CE, Hanby A et al (2007) Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res. doi:\n                        10.1186\/bcr1636","journal-title":"Breast Cancer Res"},{"key":"4542_CR37","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","volume":"14","author":"MC Cheang","year":"2008","unstructured":"Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK et al (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14:1368\u20131376","journal-title":"Clin Cancer Res"},{"key":"4542_CR38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/00313020802563510","volume":"41","author":"EA Rakha","year":"2009","unstructured":"Rakha EA, Ellis IO (2009) Triple-negative\/basal-like breast cancer: review. Pathology 41:40\u201347","journal-title":"Pathology"},{"key":"4542_CR39","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","volume":"21","author":"MD Burstein","year":"2015","unstructured":"Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA et al (2015) Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res 21:1688\u20131698","journal-title":"Clin Cancer Res"},{"key":"4542_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0550-y","author":"P Jez\u00e9quel","year":"2015","unstructured":"Jez\u00e9quel P, Loussouarn D, Gu\u00e9rin-Charbonnel C, Campion L, Vanier A, Gouraud W et al (2015) Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. Breast Cancer Res. doi:\n                        10.1186\/s13058-015-0550-y","journal-title":"Breast Cancer Res"},{"key":"4542_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-256","author":"A Estrela-Lima","year":"2010","unstructured":"Estrela-Lima A, Ara\u00fajo MS, Costa-Neto JM, Teixeira-Carvalho A, Barrouin-Melo SM, Cardoso SV et al (2010) Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates. BMC Cancer. doi:\n                        10.1186\/1471-2407-10-256","journal-title":"BMC Cancer"},{"key":"4542_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/130894","author":"MI Carvalho","year":"2014","unstructured":"Carvalho MI, Pires I, Prada J, Queiroga FL (2014) A role for T-lymphocytes in human breast cancer and in canine mammary tumors. Biomed Res Int. doi:\n                        10.1155\/2014\/130894","journal-title":"Biomed Res Int"},{"key":"4542_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157176","author":"N Maekawa","year":"2016","unstructured":"Maekawa N, Konnai S, Okagawa T, Nishimori A, Ikebuchi R, Izumi Y et al (2016) Immunohistochemical analysis of PD-L1 expression in canine malignant cancers and PD-1 expression on lymphocytes in canine oral melanoma. PLoS ONE. doi:\n                        10.1371\/journal.pone.0157176","journal-title":"PLoS ONE"},{"key":"4542_CR44","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJMoa052933","volume":"355","author":"C Fan","year":"2006","unstructured":"Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB et al (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560\u2013569","journal-title":"N Engl J Med"},{"key":"4542_CR45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2460\/javma.235.4.391","volume":"235","author":"CC Chang","year":"2009","unstructured":"Chang CC, Tsai MH, Liao JW, Chan JP, Wong ML, Chang SC (2009) Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors. J Am Vet Med Assoc 235:391\u2013396","journal-title":"J Am Vet Med Assoc"},{"key":"4542_CR46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0300985813509388","volume":"51","author":"L Pe\u00f1a","year":"2014","unstructured":"Pe\u00f1a L, Gama A, Goldschmidt MH, Abadie J, Benazzi C, Castagnaro M et al (2014) Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry. Vet Pathol 51:127\u2013145","journal-title":"Vet Pathol"},{"key":"4542_CR47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1354\/vp.37-3-239","volume":"37","author":"A Nieto","year":"2000","unstructured":"Nieto A, Pe\u00f1a L, P\u00e9rez-Alenza MD, S\u00e1nchez MA, Flores JM, Casta\u00f1o M (2000) Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol 37:239\u2013247","journal-title":"Vet Pathol"},{"key":"4542_CR48","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1007\/s00280-003-0592-1","volume":"52","author":"H Iwase","year":"2003","unstructured":"Iwase H, Zhang Z, Omoto Y, Sugiura H, Yamashita H, Toyama T et al (2003) Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer. Cancer Chemother Pharmacol 52:S34\u2013S38","journal-title":"Cancer Chemother Pharmacol"},{"key":"4542_CR49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rvsc.2012.09.016","volume":"94","author":"L Ressel","year":"2013","unstructured":"Ressel L, Puleio R, Loria GR, Vannozzi I, Millanta F, Caracappa S et al (2013) HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome. Res Vet Sci 94:299\u2013305","journal-title":"Res Vet Sci"},{"key":"4542_CR50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rvsc.2016.03.020","volume":"106","author":"MR Ara\u00fajo","year":"2016","unstructured":"Ara\u00fajo MR, Campos LC, Damasceno KA, Gamba CO, Ferreira E, Cassali GD (2016) HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: association with clinical-pathological parameters and overall survival. Res Vet Sci 106:121\u2013130","journal-title":"Res Vet Sci"},{"key":"4542_CR51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","volume":"138","author":"AC Wolff","year":"2014","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH et al (2014) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med 138:241\u2013256","journal-title":"Arch Pathol Lab Med"},{"key":"4542_CR52","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1007\/s13277-015-3661-2","volume":"36","author":"GP Burrai","year":"2015","unstructured":"Burrai GP, Tanca A, De Miglio MR, Abbondio M, Pisanu S, Polinas M et al (2015) Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer? Tumour Biol 36:9083\u20139091","journal-title":"Tumour Biol"},{"key":"4542_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-10-135","author":"P Uva","year":"2009","unstructured":"Uva P, Aurisicchio L, Watters J, Loboda A, Kulkarni A, Castle J et al (2009) Comparative expression pathway analysis of human and canine mammary tumors. BMC Genom. doi:\n                        10.1186\/1471-2164-10-135","journal-title":"BMC Genom"},{"key":"4542_CR54","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0300985810387939","volume":"48","author":"P Rivera","year":"2011","unstructured":"Rivera P, von Euler H (2011) Molecular biological aspects on canine and human mammary tumors. Vet Pathol 48:132\u2013146","journal-title":"Vet Pathol"},{"key":"4542_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1746-6148-9-78","author":"KM Paw\u0142owski","year":"2013","unstructured":"Paw\u0142owski KM, Maciejewski H, Dolka I, Mol JA, Motyl T, Kr\u00f3l M (2013) Gene expression profiles in canine mammary carcinomas of various grades of malignancy. BMC Vet Res. doi:\n                        10.1186\/1746-6148-9-78","journal-title":"BMC Vet Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4542-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4542-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4542-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T03:59:59Z","timestamp":1517284799000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4542-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["4542"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4542-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}